Li Yaobing, Pan Luqing, Yu Jinhong
The Key Laboratory of Mariculture, Ministry of Education, Ocean University of China, Qingdao, 266003, PR China.
The Key Laboratory of Mariculture, Ministry of Education, Ocean University of China, Qingdao, 266003, PR China.
Fish Shellfish Immunol. 2022 May;124:324-331. doi: 10.1016/j.fsi.2022.04.017. Epub 2022 Apr 14.
To explore the immune function of C-type lectin in shrimp, one recombinant C-type lectin (LvLec) was injected into Litopenaeus vannamei. There were four treatments in the experiment: saline group (as control group), recombinant C-type lectin group (LvLec, 1 mg mL), Vibrio harveyi group (V. harveyi, 10 cfu mL) and recombinant C-type lectin combined with Vibrio harveyi group (LvLec + V. harveyi, 1 mg mL + 10 cfu mL). The sampling time was set at 0, 3, 6, 9, 12, 24 h after the injection. The results showed that the total hemocyte count decreased significantly and the phagocytic activity improved notably after the injection of LvLec, V. harveyi or LvLec + V. harveyi. Prophenoloxidase (proPO) activity decreased, while phenoloxidase (PO) activity increased and the changing degree of each group exhibited a significant difference. The hemagglutinating activity and bacteriolytic activity improved significantly, while the antimicrobial activity did not show a remarkable change in all of the groups. There were also changes that occurred in the levels of second messengers (cAMP, cGMP) and protein kinase (PKA, PKG). After the injection of LvLec, V. harveyi or LvLec + V. harveyi, the concentration of cGMP and PKA increased significantly, while the concentration of cAMP and PKG did not change remarkably. The results above suggested that rLvLec could induce nonspecific immune response, including phagocytosis, release of PO, hemagglutination and bacteriolysis through cGMP-PKA pathway in vivo.
为探究对虾中C型凝集素的免疫功能,将一种重组C型凝集素(LvLec)注射到凡纳滨对虾体内。实验设置了四个处理组:生理盐水组(作为对照组)、重组C型凝集素组(LvLec,1 mg/mL)、哈维氏弧菌组(哈维氏弧菌,10⁶ cfu/mL)和重组C型凝集素与哈维氏弧菌联合组(LvLec + 哈维氏弧菌,1 mg/mL + 10⁶ cfu/mL)。采样时间设定为注射后0、3、6、9、12、24小时。结果显示,注射LvLec、哈维氏弧菌或LvLec + 哈维氏弧菌后,血细胞总数显著下降,吞噬活性显著提高。前酚氧化酶(proPO)活性降低,而酚氧化酶(PO)活性升高,且各组的变化程度存在显著差异。血凝活性和溶菌活性显著提高,而抗菌活性在所有组中均未表现出明显变化。第二信使(cAMP、cGMP)和蛋白激酶(PKA、PKG)水平也发生了变化。注射LvLec、哈维氏弧菌或LvLec + 哈维氏弧菌后,cGMP和PKA的浓度显著升高,而cAMP和PKG的浓度变化不明显。上述结果表明,rLvLec可通过体内cGMP - PKA途径诱导非特异性免疫反应,包括吞噬作用、PO释放、血凝和溶菌作用。